To further explore the relationship between CYP27C1 expression level and potency of protein kinase inhibitors, as well as their resistance in human lung cancer cells, we employed stable CYP27C1-knockdown A549, H1975 cells, and detected cell viability with the treatment of each inhibitor. This evidence concerns the gene CYP27C1 and lung carcinoma.